URIFIND
LIVE

Serial Number

90030700

Owner

AnchorDx Medical Co., Ltd.

Attorney

Timothy T. Wang

First Use Date

Nov 18, 2022

Filing Date

Jul 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

URIFIND Trademark

Serial Number: 90030700 • Registration: 7202367

URIFIND is a trademark filed by AnchorDx Medical Co., Ltd. on July 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

AnchorDx Medical Co., Ltd. (2 trademarks)

No.8, Unit 502, International Bio-island
Guangzhou N/A , CN

Entity Type: 99

Trademark Details

Filing Date

July 1, 2020

Registration Date

October 24, 2023

First Use Anywhere

November 18, 2022

First Use in Commerce

November 18, 2022

Published for Opposition

June 15, 2021

Goods & Services

diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for tumor therapy; organotherapy preparations; biological tissue cultures for medical purposes; medicine for tumor therapy; radioactive substances for medical purposes; media for bacteriological cultures; dietetic preparations adapted for medical purposes, namely, dietetic substances adapted for adjuvant therapy of tumors; wadding for medical purposes

medical apparatus and instruments for diagnosing and therapeutic treatment of tumors; medical apparatus and instruments for diagnosing urological conditions, namely, urological apparatus and instruments, for IVD (in vitro diagnosis); medical diagnostic apparatus for testing nucleic acids and proteins, all for medical purposes; dialyzers; apparatus for DNA and RNA testing for medical purposes; enema apparatus for medical purposes; surgical apparatus and instruments; urethral probes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 21, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 20, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 10, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 10, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 3, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 4, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 27, 2023 AITU
USE AMENDMENT FILED
Feb 8, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 8, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 10, 2022 EXRA
SOU EXTENSION 2 GRANTED
Aug 8, 2022 EX2G
SOU EXTENSION 2 FILED
Aug 8, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2022 EXRA
SOU EXTENSION 1 GRANTED
Feb 7, 2022 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 10, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 15, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2020 NWOS
NEW APPLICATION ENTERED
Jul 4, 2020 NWAP